NetworkNewsBreaks

TuesdayFeb 09, 2021 1:19 pm

NetworkNewsBreaks – Kaival Brands Innovations Group Inc. (KAVL) Announces Bidi Vapor Received FDA PMTA Acceptance Letter for all 11 Bidi Stick Products

Kaival Brands (OTCQB: KAVL), a company focused on generating shareholder value by incubating innovative products into mature and dominant brands within their respective markets, has announced that Bidi(R) Vapor has received a PMTA acceptance letter from the U.S. Food and Drug Administration (“FDA”). Kaival is the exclusive global distributor of Bidi Vapor LLC products. The PMTA letter marks an important milestone Bidi’s overall application is one step closer to meeting the FDA’s baseline criteria before moving into the substantive review, which is the final phase of the PMTA process. The PMTAa for Bidi Vapor now move on to the filing review…

Continue Reading

TuesdayFeb 09, 2021 1:07 pm

NetworkNewsBreaks – GoldHaven Resources Corp. (CSE: GOH) (OTCQB: GHVNF) (FSE: 4QS) Commences Phase I Drill Campaign at Rio Loa

GoldHaven Resources (CSE: GOH) (OTCQB: GHVNF) (FSE: 4QS), a Canada-based company engaged in the business of acquiring and exploring mineral resource properties, today announced that the drill crew has been mobilized over the weekend and has commenced its 5,000-meter Phase I drill campaign starting at Rio Loa. The Rio Loa Project is located 25 km south of Gold Field's Salares Norte deposit (5.2 million ounces equivalent of Gold scheduled to produce 350,000 oz of Gold per annum) and 6 km south of Gold Field's Horizonte discovery. "This is a major milestone in our development to unlock the potential of our…

Continue Reading

TuesdayFeb 09, 2021 12:15 pm

NetworkNewsBreaks – Spectrum Global Solutions Inc. (SGSI) Announces High Wire’s Achievement of SOC 2 Type 1 Certification

Spectrum Global Solutions (OTCQB: SGSI), a single-source provider of next-generation communications network and professional services to telecommunications and enterprise markets, today announced that High Wire Networks Inc. and its cybersecurity business unit, Overwatch Managed Security, have achieved SOC 2 Type 1 certification. According to the update, SOC 2 is a technical audit that requires companies to establish strict information security policies and procedures to protect customer data. “SOC 2 Type 1 certification proves High Wire’s information security measures are in line with the unique parameters of today’s cloud requirements and that systems for shared access to the cloud are safely…

Continue Reading

TuesdayFeb 09, 2021 12:05 pm

NetworkNewsBreaks — MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0) Releases Further Lab Results Validating Natural Biopesticide Control of Banana Disease

MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0), an agriculture biotech company focused on providing natural science-based biological solutions for high-value crops, as released additional lab results confirming its mustard-derived natural biopesticide ability to obtain 100% control of on the disease Fusarium wilt TR4. A banana disease often referred to as the Panama disease, Fusarium wilt TR4 is destroying the $25 billion global banana industry. These most-recent results were conducted by a third party and validate earlier test results that confirm the efficacy of MustGrow’s safe and effective natural, plant-based biopesticide. The test results confirm 100% control achieved at economic…

Continue Reading

TuesdayFeb 09, 2021 11:46 am

NetworkNewsBreaks – HempFusion Wellness Inc. (TSX: CBD.U) (OTC: CBDHF) (FWB: 8OO) CMO to Serve 2nd Consecutive Term as President of US Hemp Roundtable

HempFusion Wellness (TSX: CBD.U) (OTC: CBDHF) (FWB: 8OO), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, today announced that its Chief Marketing Officer, Ola Lessard, was elected president of the U.S. Hemp Roundtable for a second consecutive term. The “Roundtable” is one of the most influential non-profit organizations advocating for national hemp legislation in the United States. This election makes Lessard not only the first woman, but also the first two-term president in the organization’s history. “I am truly honored by the confidence my peers have shown in me by electing me to a…

Continue Reading

TuesdayFeb 09, 2021 11:15 am

NetworkNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Releases Preliminary Q4 2020 Revenue, Forecast Numbers

The Green Organic Dutchman (TSX: TGOD) (OTCQX: TGODF), a leading producer of premium certified organically grown cannabis, has announced its Q4 2020 preliminary, unaudited revenue numbers. According to the release, the company reached $10.9 million in unaudited gross revenue in Q4 2020 for the period, with an increase in quarter-over-quarter revenue of 91%. The company also released an updated revenue forecast. The Q4 revenue is a 235% increase over the previous year. In the announcement, the company noted that the numbers reflect the significant progress and growth achieved in its Canadian operations and sales, which accounted for $8.6 million of the…

Continue Reading

TuesdayFeb 09, 2021 10:54 am

NetworkNewsBreaks – Exro Technologies Inc. (TSX.V: EXRO) (OTCQB: EXROF) Expands SEA Electric Partnership to Accelerate ‘BCS’ Development

Exro Technologies (TSX.V: EXRO) (OTCQB: EXROF), a leading clean technology company that has developed a new class of power electronics for electric motors and batteries, today announced that it has expanded its strategic partnership with SEA Electric Pty Ltd. ("SEA Electric" or "SEA") to accelerate development of Exro's Battery Control System ("BCS"). SEA Electric is a widely recognized market leader in the electrification of commercial vehicles with operations in five countries and over one million miles of independent original equipment manufacturer ("OEM") tested and in-service operation. Under the expanded strategic collaboration, SEA Electric will provide Exro with two electric delivery…

Continue Reading

TuesdayFeb 09, 2021 10:24 am

NetworkNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Forms Clinical Advisory Board, Announces $25M Registered Direct Offering

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, has announced that it has created a Clinical Advisory Board (“CAB”). The company has named world-renowned medical and clinical experts as the board’s first members. The purpose of the board is to provide expert guidance for Genprex’s novel gene therapy clinical development programs in cancer and diabetes. More specifically, CAB members will provide invaluable guidance and advise as Genprex advances its REQORSA(TM) (“REQORSA”) immunogene therapy program and its preclinical diabetes gene therapy program. Board members include the following: Michael Morse, MD, MHS,…

Continue Reading

TuesdayFeb 09, 2021 10:18 am

NetworkNewsBreaks – Excellon Resources Inc. (TSX: EXN) (NYSE American: EXN) (FSE: E4X2) Announces Update on Platosa Project Exploration, Compelling Targets

Excellon Resources (TSX: EXN) (NYSE American: EXN) (FSE: E4X2) today provided an update on ongoing exploration at the Platosa Project in Durango, Mexico, where four diamond drill rigs are currently active. "Exploration at Platosa continues to deliver compelling targets at a mine and regional level," said Ben Pullinger, SVP Geology and Corporate Development. "We are currently drilling regional discovery targets, with the Jaboncillo alteration zone representing a potentially larger-scale Platosa-style deposit and the PDN geophysical anomaly potentially representing a skarn-body associated with our Rincón del Caído discovery in 2012. Additionally, we continue to define the new 10-20 target, just south…

Continue Reading

TuesdayFeb 09, 2021 9:47 am

NetworkNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Enters Collaboration for Planned Phase 2 Clinical Trial of FW-1022

AzurRx BioPharma (NASDAQ: AZRX), a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (“GI”) diseases, today announced its entry into an agreement with PPD Inc. (NASDAQ: PPD ), a leading global contract research organization (“CRO”), for its planned Phase 2 clinical trial evaluating a proprietary formulation of micronized niclosamide as a treatment for COVID-19-associated GI infections. Under the agreement, PPD will manage the Phase 2 clinical trial for an immediate-release capsule formulation of micronized oral niclosamide, also known as FW-1022. Licensed in January from FirstWave Bio Inc., the goal of AzurRx’s FW-1022 clinical program is…

Continue Reading